THDB
6008678.370.36% ( +0.03 )
THDB (600867)
Tonghua Dongbao Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of biological products, tra...
- Open
- 8.34
- High
- 8.44
- Low
- 8.31
- Prev. Close
- 8.34
- Volume
- 216.15K
- Turnover
- 181.00M
- Avg Price
- 8.37
- Bid/Ask Ratio
- --
- Amplitude
- 1.56%
- 52wk High
- 10.37
- Volume Ratio
- 0.53
- Turnover Ratio
- 1.10%
THDB Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
¥9.5413.98%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy20.00%
- Hold0.00%
- Sell20.00%
- Strong sell0.00%
News
- Yicai · Jul 28 at 05:28 AM
First China-Made Rapid-Acting Insulin Wins US FDA Approval
- PUBT · Jul 23 at 11:00 AM
Adocia Notifies Availability of Q2 2026 Financial Results Press Release
- Zhitong · Oct 24, 2025 at 02:46 AM
THDB: The winter insulin injection has obtained an overseas drug registration certificate
- Zhitong · Oct 22, 2025 at 03:25 AM
THDB: Announced the shareholding status of the top ten shareholders and the top ten unrestricted shareholders before the share repurchase
- Zhitong · Oct 17, 2025 at 03:46 AM
THDB plans to repurchase company shares for between 20 million and 40 million yuan
- Zhitong · Oct 10, 2025 at 04:07 AM
THDB: Insulin Glargine Injection has obtained overseas listing approval
